|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0023981,
umls-concept:C0026538,
umls-concept:C0026565,
umls-concept:C0028127,
umls-concept:C0034656,
umls-concept:C0038454,
umls-concept:C0287041,
umls-concept:C0401925,
umls-concept:C0679699,
umls-concept:C0681867,
umls-concept:C1274040,
umls-concept:C1707455
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2005-5-25
|
|
pubmed:abstractText |
In hypertensive stroke patients, for the same level of blood pressure control, eprosartan will be more effective than nitrendipine in reducing cerebrovascular and cardiovascular morbidity and mortality.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1524-4628
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1218-26
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15879332-Acrylates,
pubmed-meshheading:15879332-Aged,
pubmed-meshheading:15879332-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:15879332-Antihypertensive Agents,
pubmed-meshheading:15879332-Blood Pressure,
pubmed-meshheading:15879332-Body Mass Index,
pubmed-meshheading:15879332-Calcium,
pubmed-meshheading:15879332-Cardiovascular Diseases,
pubmed-meshheading:15879332-Female,
pubmed-meshheading:15879332-Humans,
pubmed-meshheading:15879332-Hypertension,
pubmed-meshheading:15879332-Imidazoles,
pubmed-meshheading:15879332-Magnetic Resonance Spectroscopy,
pubmed-meshheading:15879332-Male,
pubmed-meshheading:15879332-Middle Aged,
pubmed-meshheading:15879332-Nitrendipine,
pubmed-meshheading:15879332-Prospective Studies,
pubmed-meshheading:15879332-Recurrence,
pubmed-meshheading:15879332-Risk Factors,
pubmed-meshheading:15879332-Single-Blind Method,
pubmed-meshheading:15879332-Sodium Chloride Symporter Inhibitors,
pubmed-meshheading:15879332-Stroke,
pubmed-meshheading:15879332-Thiophenes,
pubmed-meshheading:15879332-Time Factors,
pubmed-meshheading:15879332-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).
|
|
pubmed:affiliation |
Department of Internal Medicine, St. Josefs Hospital, Cloppenburg, Germany.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
